查看文章

The multiparametric assessment of liver fibrosis, steatosis and inflammation offers valuable prognostic information in chronic liver disease (CLD) patients (1). The current study aims to evaluate the feasibility and performance of three new ultrasound-based techniques for the noninvasive assessment of liver fibrosis, steatosis and inflammation in CLD patients.

209-consecutive compensated CLD patients were included in the study. Ultrasound-based measurements were performed in all patients, in the same session, using ShearWave Elastography (2D-SWE.PLUS), Attenuation Plane-wave Ultrasound (Att.PLUS), Viscosity Plane-wave Ultrasound (Vi.PLUS) from Aixplorer and Transient Elastography (TE) with Controlled Attenuation Parameter (CAP) from FibroScan as reference method.

Valid measurements were obtained in 99% of patients by TE, in 89% of patients by 2D-SWE.PLUS/Vi …